← FDA Drug Approvals (Drugs@FDA)
LOTEMAX
NDA · New Drug Application · Sponsor: PHARMOS · Approved 1998-03-09
Drug application
- FDA Application #
NDA020841- Application type
- New Drug Application
- Brand name
- LOTEMAX
- Generic name
- Loteprednol Etabonate
- Active ingredients
- LOTEPREDNOL ETABONATE
- Dosage form
- SUSPENSION/DROPS
- Route
- OPHTHALMIC
- Marketing status
- Discontinued
- Sponsor
- PHARMOS
- First approval
- 1998-03-09
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown